Centers | ||
|
|
|
Therapeutic Accelerator Program (TAP) | Saint Louis University Institute for Drug and Biotherapeutic Innovation (IDBI) | test |
Test |
The IDBI is a decentralized, collaborative institute whose mission is to promote the translation of research projects at Saint Louis University through drug discovery and pre-clinical development. The IDBI achieves this through four main... |
sfgd |
Partnerships |
Events |
Jobs |
Elan and University of Cambridge Establish New Innovation CenterUniversity of Cambridge and Elan jointly established Cambridge - Elan Centre for Research Innovation and Drug Discovery. The new center will be based out of Cambridge and will focus primarily in developing innovative therapies to treat Alzheimer's... View all Sanofi to Collaborate with UCSF to Develop New Drugs to Treat DiabetesUniversity of California, San Francisco (UCSF) has entered into a broad collaboration agreement with Sanofi to develop new therapies to treat Diabetes (Type 1 & 2). Scientists with deep biology expertise at Sanofi will be partnering with... View all Janssen Partners with Evotec-Harvard Diabetes Collaboration ProgramJanssen Pharmaceutical a division of Johnson & Johnson has entered into partnership with Harvard University - Evotec's Diabetes program called CureBeta. Janssen will paying $300million in milestone payments per product in addition to $8million in... View all |
No EVENTS for listing |
No Job Posts |
